|
2023
|
Invention
|
Treatment of androgen deprivation therapy associated symptoms.
The present invention provides a ... |
|
2019
|
Invention
|
Hydrochloride salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza... |
|
2018
|
Invention
|
Nk 1 antagonists.
A compound having the general structure shown in Formula I:
A compound havin... |
|
2017
|
Invention
|
Nk1 antagonists.
A NK1 antagonist having the formula (I),
A NK1 antagonist having the formula ... |
|
2016
|
Invention
|
1 antagonists. A compound having the general structure shown in Formula I:
1 receptors, for exam... |
|
|
Invention
|
Heteroaryl carbonitriles for the treatment of disease.
The invention relates to pharmaceutical c... |
|
|
Invention
|
Heteroaryl carbonitriles for the treatment of disease. The invention relates to pharmaceutical co... |
|
|
Invention
|
Hypersulfated disaccharide formulations.
Hypersulfated disaccharides with utility in asthma or a... |
|
|
Invention
|
Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-me... |
|
2015
|
Invention
|
Intravenous formulations of neurokinin-1 antagonists.
Pharmaceutical compositions for intravenou... |
|
|
Invention
|
Hypersulfated disaccharides to treat elastase related disorders.
Hypersulfated disaccharides of ... |
|
|
Invention
|
Hydrochloride salts of 8-[1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diazaspi... |
|
2014
|
G/S
|
Printed reports featuring laboratory, clinical and diagnostic testing information and results; pr... |
|
|
G/S
|
Pharmaceutical preparations and compounds; therapeutic
preparations and compounds; veterinary pr... |
|
|
G/S
|
Chemical diagnostic preparations for clinical and medical laboratory use; Chemical diagnostic rea... |
|
|
G/S
|
Chemical diagnostic preparations for clinical laboratory use; chemical diagnostic reagents for cl... |
|
|
G/S
|
[ chemical preparations for scientific purposes; chemical preparations, namely, diagnostic reagen... |
|
|
Invention
|
Tablet formulations containing 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tab... |
|
|
Invention
|
1 antagonists. 1 antagonist having the formula (I),
5 are not both H or alkyl, and the remaining... |
|
|
G/S
|
Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; me... |
|
|
G/S
|
Chemical preparations; chemical reagents; diagnostic test kits and reagents for scientific and re... |
|
2013
|
Invention
|
Hypersulfated disaccharide formulations. Hypersulfated disaccharides with utility in asthma or as... |
|
|
Invention
|
Oral dosage form of 25-hydroxyvitamin d. 3. |
|
|
Invention
|
Pharmaceutical formulations: salts of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxy-methyl]-8-phen... |
|
2012
|
Invention
|
Nk1 antagonists. 1 antagonist having the formula (I),
5 are not both H or alkyl, and the remaini... |
|
|
G/S
|
Research and development in the pharmaceutical, diagnostic and biotechnology fields. |
|
|
G/S
|
Research and development in the pharmaceutical, diagnostic
and biotechnology fields. |
|
2011
|
Invention
|
Hypersulfated disaccharides to treat elastase related disorders. Hypersulfated disaccharides of f... |
|
|
Invention
|
Nk1 antagonists. A compound having the general structure shown in Formula I:
1 receptors, for ex... |
|
|
Invention
|
Pharmaceutical formulations:salts of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl... |
|
|
Invention
|
Hypersulfated glucopyranosides. Hypersulfated disaccharides, preferably octasulfated sucrose, wit... |
|
|
Invention
|
Hypersulfated glucopyranosides.
Hypersulfated disaccharides, preferably octasulfated sucrose, wi... |
|
2010
|
Invention
|
Intravenous formulations of neurokinin-1 antagonists. Pharmaceutical compositions for intravenous... |
|
|
Invention
|
Identification of small molecules recognized by antibodies in subjects with neurodegenerative dis... |
|
|
Invention
|
Peptoid ligands for isolation and treatment of autoimmune t-cells. The present invention provides... |
|
2009
|
Invention
|
Pharmaceutical formulations: salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-p... |
|
2008
|
Invention
|
Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic... |
|
|
Invention
|
Tablet formulations containing 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1... |
